Developer of a real-time analytics and care guidance platform designed to incorporate predictive analytics and machine l
Developer of a real-time analytics and care guidance platform designed to incorporate predictive analytics and machine learning into the design of care delivery models.
Enterprise Systems (Healthcare)📍 San Francisco, CAFounded 2015
Current Valuation
$1.5B
as of 2022-Q2
UNICORN
QL Price
$907.67M
-39% vs last round
QuantLogix's current estimate for Clarify Health, published 2026-09-27 — below the last disclosed round of $1.5B (2022-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.5B
2022-Q2
weight 0.05
Secondary market print
$853.5M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Clarify Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Clarify Health, 2026-09-27 (20c997d254ade9cb).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Clarify Health going public?
No. Clarify Health is private and has not filed to go public. There is no S-1 on file.
What is Clarify Health's valuation in 2026?
Clarify Health is valued at $1.5B as of 2022-Q2, set by its Series D ($150M, Apr 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Clarify Health filed an S-1?
No public S-1 is on file for Clarify Health.
How much has Clarify Health raised?
Clarify Health has raised $352.96M in total, most recently a Series D of $150M in Apr 2022.
Is Clarify Health publicly traded — can you buy Clarify Health stock?
No. Clarify Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Clarify Health on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2015
HQ
San Francisco, CA
Employees
238
Total Raised
$352.96M
Last Round
Series D — $150M (Apr 2022)
IPO Status
private
Fundraising Status
Series D · $150M · 4y 5mo ago
privateTotal raised $352.96M
Secondary Market
Implied price / share
$5.3
Last round price / share
$9.32
vs last round
-43.1%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$150M
Apr 2022
—
$1.5B
Talent Signal
Hiring trend
▲ Hiring uptrend
+67% vs 2026-08
Open roles
5
via lever
Product-build share
40%
engineering, research, product, design
Trajectory
scaling
balanced build + GTM — 40% builders vs 60% go-to-market/G&A — scaling both sides.
Executive bench growing while hiring expands: 1 senior hire (CEO); open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INCo-Founder Todd GottulaCEO · 2026-08-12
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Counted from Clarify Health's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
MedicalHealth CareArtificial IntelligenceAnalyticsManagement Information Systems
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.